Bausch + Lomb Shares Outstanding 2021-2024 | BLCO
Bausch + Lomb shares outstanding history from 2021 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
- Bausch + Lomb shares outstanding for the quarter ending March 31, 2024 were 0.351B, a 0.31% increase year-over-year.
- Bausch + Lomb 2023 shares outstanding were 0.351B, a 0.09% increase from 2022.
- Bausch + Lomb 2022 shares outstanding were 0.35B, a 0.06% increase from 2021.
- Bausch + Lomb 2021 shares outstanding were 0.35B, a 0% decline from 2020.
| Bausch + Lomb Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2023 | 351 |
| 2022 | 350 |
| 2021 | 350 |
| 2020 | 350 |
| Bausch + Lomb Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2024-03-31 | 351 |
| 2023-12-31 | 351 |
| 2023-09-30 | 351 |
| 2023-06-30 | 350 |
| 2023-03-31 | 350 |
| 2022-12-31 | 350 |
| 2022-09-30 | 350 |
| 2022-06-30 | 350 |
| 2022-03-31 | 350 |
| 2021-12-31 | 350 |
| 2021-09-30 | 350 |
| 2021-06-30 | 350 |
| 2021-03-31 | 350 |
| 2020-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $5.256B | $4.146B |
| Bausch Lomb Corporation is an eye health company. Its product portfolio includes Biotrue(R) and renu(R) multi-purpose solutions, Biotrue(R) ONEday daily disposable contact lenses, LUMIFY(R) redness reliever eye drops, PreserVision(R) AREDS 2 formula eye vitamin and mineral supplements and VYZULTA(R). Bausch Lomb Corporation is based in VAUGHAN, ON. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $124.199B | 15.58 |
| Cencora (COR) | United States | $46.811B | 18.25 |
| ICON (ICLR) | Ireland | $26.101B | 24.64 |
| DiDi Global (DIDIY) | China | $21.629B | 0.00 |
| Avantor (AVTR) | United States | $14.672B | 21.60 |
| CochLear (CHEOY) | Australia | $14.178B | 0.00 |
| Natera (NTRA) | United States | $13.560B | 0.00 |
| Revvity (RVTY) | United States | $13.251B | 23.25 |
| Medpace Holdings (MEDP) | United States | $12.268B | 40.36 |
| Viatris (VTRS) | United States | $12.038B | 3.60 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $10.901B | 0.00 |
| Charles River Laboratories (CRL) | United States | $10.735B | 20.55 |
| Solventum (SOLV) | United States | $9.435B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.186B | 0.00 |
| HealthEquity (HQY) | United States | $7.341B | 47.13 |
| Organon (OGN) | United States | $5.233B | 4.96 |
| Doximity (DOCS) | United States | $5.207B | 36.47 |
| PACS (PACS) | United States | $4.420B | 0.00 |
| Life Times (LTH) | United States | $3.669B | 38.44 |
| Sotera Health (SHC) | United States | $3.216B | 15.78 |
| Surgery Partners (SGRY) | United States | $3.194B | 29.22 |
| GoodRx Holdings (GDRX) | United States | $3.148B | 119.86 |
| Agilon Health (AGL) | United States | $2.735B | 0.00 |
| Progyny (PGNY) | United States | $2.543B | 43.79 |
| NovoCure (NVCR) | Jersey | $2.088B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.048B | 8.12 |
| Premier (PINC) | United States | $1.897B | 8.12 |
| BrightSpring Health Services (BTSG) | United States | $1.782B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.715B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.566B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $1.510B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.189B | 0.00 | |
| Embecta (EMBC) | United States | $0.725B | 4.93 |
| GeneDx Holdings (WGS) | United States | $0.725B | 0.00 |
| CareDx (CDNA) | United States | $0.705B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.631B | 6.70 |
| Auna S.A (AUNA) | Luxembourg | $0.599B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.583B | 15.27 |
| InnovAge Holding (INNV) | United States | $0.574B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.465B | 0.00 |
| Enhabit (EHAB) | United States | $0.443B | 44.20 |
| ModivCare (MODV) | United States | $0.403B | 7.54 |
| Sonida Senior Living (SNDA) | United States | $0.391B | 0.00 |
| LifeMD (LFMD) | United States | $0.349B | 0.00 |
| DocGo (DCGO) | United States | $0.318B | 17.39 |
| Sharecare (SHCR) | United States | $0.290B | 0.00 |
| MultiPlan (MPLN) | United States | $0.257B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.246B | 0.00 |
| Beauty Health (SKIN) | United States | $0.225B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.187B | 0.00 |
| Biodesix (BDSX) | United States | $0.185B | 0.00 |
| So-Young (SY) | China | $0.111B | 53.50 |
| Pono Capital Two (PTWO) | United States | $0.069B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.045B | 0.00 |
| NeueHealth (NEUE) | United States | $0.044B | 5.92 |
| IceCure Medical (ICCM) | Israel | $0.035B | 0.00 |
| Oncology Institute (TOI) | United States | $0.034B | 0.00 |
| Nutex Health (NUTX) | United States | $0.029B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.025B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.025B | 0.00 |
| OncoCyte (OCX) | United States | $0.023B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.020B | 0.00 |
| KindlyMD (KDLY) | $0.016B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.013B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| DermTech (DMTK) | United States | $0.012B | 0.00 |
| XWELL (XWEL) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| ISpecimen (ISPC) | United States | $0.006B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.004B | 0.00 |
| OpGen (OPGN) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Assure Holdings (IONM) | United States | $0.001B | 0.00 |